Research ArticleAccepted Article
Impact of gut involvement in patients with high probability of early spondyloarthritis. Data from DESIR cohort.
Daniel Wendling, Xavier Guillot, Clément Prati, Corinne Miceli-Richard, Anna Molto, Rik Lories and Maxime Dougados
The Journal of Rheumatology June 2019, jrheum.181326; DOI: https://doi.org/10.3899/jrheum.181326
Daniel Wendling
From the Rheumatology, CHRU de Besançon (University Teaching Hospital), Boulevard Fleming, 25030 Besançon, France; Université Bourgogne Franche-Comté, EA4266 (Pathogens and Inflammation, EPILAB), Besançon, France; Université Bourgogne Franche-Comté, EA4267 (PEPITE), FHU INCREASE, Besançon, France; Paris Descartes University, Department of Rheumatology, Hôpital Cochin, AP-HP, EULAR center of excellence, Paris , France; INSERM (U1153): Clinical epidemiology and biostatistics, PRES Sorbonne Paris-Cité, Paris 14, France; Division of Rheumatology, Department of Development and Regeneration, University Hospital Leuven, KU Leuven, Leuven, Belgium.
Xavier Guillot
From the Rheumatology, CHRU de Besançon (University Teaching Hospital), Boulevard Fleming, 25030 Besançon, France; Université Bourgogne Franche-Comté, EA4266 (Pathogens and Inflammation, EPILAB), Besançon, France; Université Bourgogne Franche-Comté, EA4267 (PEPITE), FHU INCREASE, Besançon, France; Paris Descartes University, Department of Rheumatology, Hôpital Cochin, AP-HP, EULAR center of excellence, Paris , France; INSERM (U1153): Clinical epidemiology and biostatistics, PRES Sorbonne Paris-Cité, Paris 14, France; Division of Rheumatology, Department of Development and Regeneration, University Hospital Leuven, KU Leuven, Leuven, Belgium.
Clément Prati
From the Rheumatology, CHRU de Besançon (University Teaching Hospital), Boulevard Fleming, 25030 Besançon, France; Université Bourgogne Franche-Comté, EA4266 (Pathogens and Inflammation, EPILAB), Besançon, France; Université Bourgogne Franche-Comté, EA4267 (PEPITE), FHU INCREASE, Besançon, France; Paris Descartes University, Department of Rheumatology, Hôpital Cochin, AP-HP, EULAR center of excellence, Paris , France; INSERM (U1153): Clinical epidemiology and biostatistics, PRES Sorbonne Paris-Cité, Paris 14, France; Division of Rheumatology, Department of Development and Regeneration, University Hospital Leuven, KU Leuven, Leuven, Belgium.
Corinne Miceli-Richard
From the Rheumatology, CHRU de Besançon (University Teaching Hospital), Boulevard Fleming, 25030 Besançon, France; Université Bourgogne Franche-Comté, EA4266 (Pathogens and Inflammation, EPILAB), Besançon, France; Université Bourgogne Franche-Comté, EA4267 (PEPITE), FHU INCREASE, Besançon, France; Paris Descartes University, Department of Rheumatology, Hôpital Cochin, AP-HP, EULAR center of excellence, Paris , France; INSERM (U1153): Clinical epidemiology and biostatistics, PRES Sorbonne Paris-Cité, Paris 14, France; Division of Rheumatology, Department of Development and Regeneration, University Hospital Leuven, KU Leuven, Leuven, Belgium.
Anna Molto
From the Rheumatology, CHRU de Besançon (University Teaching Hospital), Boulevard Fleming, 25030 Besançon, France; Université Bourgogne Franche-Comté, EA4266 (Pathogens and Inflammation, EPILAB), Besançon, France; Université Bourgogne Franche-Comté, EA4267 (PEPITE), FHU INCREASE, Besançon, France; Paris Descartes University, Department of Rheumatology, Hôpital Cochin, AP-HP, EULAR center of excellence, Paris , France; INSERM (U1153): Clinical epidemiology and biostatistics, PRES Sorbonne Paris-Cité, Paris 14, France; Division of Rheumatology, Department of Development and Regeneration, University Hospital Leuven, KU Leuven, Leuven, Belgium.
Rik Lories
From the Rheumatology, CHRU de Besançon (University Teaching Hospital), Boulevard Fleming, 25030 Besançon, France; Université Bourgogne Franche-Comté, EA4266 (Pathogens and Inflammation, EPILAB), Besançon, France; Université Bourgogne Franche-Comté, EA4267 (PEPITE), FHU INCREASE, Besançon, France; Paris Descartes University, Department of Rheumatology, Hôpital Cochin, AP-HP, EULAR center of excellence, Paris , France; INSERM (U1153): Clinical epidemiology and biostatistics, PRES Sorbonne Paris-Cité, Paris 14, France; Division of Rheumatology, Department of Development and Regeneration, University Hospital Leuven, KU Leuven, Leuven, Belgium.
Maxime Dougados
From the Rheumatology, CHRU de Besançon (University Teaching Hospital), Boulevard Fleming, 25030 Besançon, France; Université Bourgogne Franche-Comté, EA4266 (Pathogens and Inflammation, EPILAB), Besançon, France; Université Bourgogne Franche-Comté, EA4267 (PEPITE), FHU INCREASE, Besançon, France; Paris Descartes University, Department of Rheumatology, Hôpital Cochin, AP-HP, EULAR center of excellence, Paris , France; INSERM (U1153): Clinical epidemiology and biostatistics, PRES Sorbonne Paris-Cité, Paris 14, France; Division of Rheumatology, Department of Development and Regeneration, University Hospital Leuven, KU Leuven, Leuven, Belgium.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Accepted manuscript
Impact of gut involvement in patients with high probability of early spondyloarthritis. Data from DESIR cohort.
Daniel Wendling, Xavier Guillot, Clément Prati, Corinne Miceli-Richard, Anna Molto, Rik Lories, Maxime Dougados
The Journal of Rheumatology Jun 2019, jrheum.181326; DOI: 10.3899/jrheum.181326
Accepted manuscript
Impact of gut involvement in patients with high probability of early spondyloarthritis. Data from DESIR cohort.
Daniel Wendling, Xavier Guillot, Clément Prati, Corinne Miceli-Richard, Anna Molto, Rik Lories, Maxime Dougados
The Journal of Rheumatology Jun 2019, jrheum.181326; DOI: 10.3899/jrheum.181326